Quantification of anticholinergic and sedative drug load with the Drug Burden Index: a review of outcomes and methodological quality of studies Hans WoutersHelene van der MeerKatja Taxis Review Open access 01 December 2016 Pages: 257 - 266
Association of oral endothelin receptor antagonists with risks of cardiovascular events and mortality: meta-analysis of randomized controlled trials Yu PanChun HuHui Min Jin Clinical Trial 13 December 2016 Pages: 267 - 278
The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus Caroline DudkowskiMax TsaiJeannie Xie Clinical Trial Open access 20 December 2016 Pages: 279 - 288
Association between N-desethylamiodarone/amiodarone ratio and amiodarone-induced thyroid dysfunction Mikie YamatoKyoichi WadaMitsutaka Takada Pharmacodynamics 12 January 2017 Pages: 289 - 296
Integrating health technology assessment requirements in the clinical development of medicines: the experience from NICE scientific advice François MaignenLeeza OsipenkoEmily Crowe Pharmacoeconomics 10 December 2016 Pages: 297 - 305
Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy Yao LuYouxin FangLan Xu Pharmacogenetics 29 November 2016 Pages: 307 - 315
Impact of genetic and nongenetic factors on interindividual variability in 4β-hydroxycholesterol concentration Kristine HoleC. GjestadS. Bremer Pharmacogenetics 14 December 2016 Pages: 317 - 324
Clinical pharmacokinetics of magnesium sulfate in the treatment of children with severe acute asthma Joseph E. RowerXiaoxi LiuMichael D. Johnson Pharmacokinetics and Disposition 02 December 2016 Pages: 325 - 331
Population pharmacokinetics of meropenem in elderly patients: dosing simulations based on renal function Muhammad UsmanOtto R. FreyGeorg Hempel Pharmacokinetics and Disposition 13 December 2016 Pages: 333 - 342
The influence of piperine on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy volunteers Satish Kumar BedadaPraveen Kumar Boga Pharmacokinetics and Disposition 15 December 2016 Pages: 343 - 349
Factors associated with expression of extrapyramidal symptoms in users of atypical antipsychotics Susana Barbosa RibeiroAurigena Antunes de AraújoRand Randall Martins Pharmacoepidemiology and Prescription 26 November 2016 Pages: 351 - 355
Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma Shinichi WatanabeYui KuwabaraHiroaki Araki Pharmacoepidemiology and Prescription 26 November 2016 Pages: 357 - 363
Risk of parkinsonism induced by flunarizine or cinnarizine: a population-based study Hsiu-Li LinHsiu-Chen LinChien-Yeh Hsu Pharmacoepidemiology and Prescription 16 December 2016 Pages: 365 - 371
How can we define and analyse drug exposure more precisely to improve the prediction of hospitalizations in longitudinal (claims) data? Andreas D. MeidAndreas GrollWalter E. Haefeli Point of View 24 December 2016 Pages: 373 - 380